Burning Rock Biotech Limited Share Price

Burning Rock Biotech Limited Share Price

NASDAQ: BNR
$11.27
-$0.94 (-7.7%) Last updated on 30 Oct, 2026 | 01:22 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Burning Rock Biotech Limited Stock Performance

Open
$11.16
Prev. Close
$12.21
Circuit Range
N/A
Day Range
$11.16 - $11.43
Year Range
$6.98 - $41.09
Volume
733
Average Traded
$11.23

Burning Rock Biotech Limited Share Price Today

As of 30 October 2026, Burning Rock Biotech Limited's share price is $11.27. The stock opened at $11.16, compared to its previous close of $12.21. During today's trading session, Burning Rock Biotech Limited's share price traded between $11.16 and $11.43, with an average price of $11.29. Over the past 52 weeks, the stock has recorded a high of $41.09 and a low of $6.98. In terms of performance, Burning Rock Biotech Limited's share price has declined by 31.96% over the last six months and is down 11.54% on a year-on-year basis.

Burning Rock Biotech Limited Share Price Chart

Line chart of the Burning Rock Biotech Limited price trend over the selected period. The price fell overall, ranging from 10.83 to 12.20, ending at 11.27.
$11.16$11.43
L
Show Current Price
H

Burning Rock Biotech Limited Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
N/A
EPS (TTM)
N/A
Revenue (TTM)
$77.12B
Return On Equity (TTM)
N/A
Profit Margin
-10.26%
Debt to Equity
N/A
Quarterly Earnings Growth YoY
N/A

Burning Rock Biotech Limited Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$81.65$75.92$70.67$77.12
Net Profit-$140.80-$92.35-$47.49-$7.91
Net Profit Margin-172.44%-121.64%-67.20%-10.26%
Income ChangeN/A34.41%48.58%83.34%

About Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. The Group provides pharma research and development services, mainly cancer therapy selection tests services, companion diagnostics development services, and other service agreements with the combination of various customized tests services and analytical validation services, to pharmaceutical companies for developing new drugs for targeted therapies, immunotherapies on various types of cancers, and to hospitals for their studies on cancer diagnosis & treatment. It had three operating segments, including the Central laboratory business, the In-hospital business, & Pharma research & development services. It generates the majority of its revenue from the Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, & others.

Burning Rock Biotech Limited Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$16.10
$11.43
-39.02%
Sep 2026
$9.43
$18.75
+105.09%
Aug 2026
$10.87
$9.14
-16.76%
Jul 2026
$10.07
$10.98
+36.23%
Jun 2026
$8.93
$8.06
-33.00%
May 2026
$17.09
$12.03
-27.38%
Apr 2026
$16.89
$16.57
+1.63%
Mar 2026
$21.16
$16.30
-33.25%
Feb 2026
$35.61
$24.42
-27.61%
Jan 2026
$20.00
$33.73
+64.60%
Dec 2025
$22.12
$20.50
-4.85%
Nov 2025
$13.18
$21.54
+69.07%

BNR Share Price FAQs